These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 30481110

  • 21. Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12-23 months.
    Zepp F, Behre U, Kindler K, Laakmann KH, Pankow-Culot H, Mannhardt-Laakmann W, Beckers F, Descamps D, Willems P.
    Eur J Pediatr; 2007 Aug; 166(8):857-64. PubMed ID: 17541639
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles-mumps-rubella-varicella vaccine to children aged 11-21 months.
    Knuf M, Zepp F, Meyer CU, Habermehl P, Maurer L, Burow HM, Behre U, Janssens M, Willems P, Bisanz H, Vetter V, Schmidt-Ott R.
    Eur J Pediatr; 2010 Aug; 169(8):925-33. PubMed ID: 20148263
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A new combination vaccine for measles, mumps, rubella and varicella.
    Zareba G.
    Drugs Today (Barc); 2006 May; 42(5):321-9. PubMed ID: 16801995
    [Abstract] [Full Text] [Related]

  • 28. Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial.
    Prymula R, Bergsaker MR, Esposito S, Gothefors L, Man S, Snegova N, Štefkovičova M, Usonis V, Wysocki J, Douha M, Vassilev V, Nicholson O, Innis BL, Willems P.
    Lancet; 2014 Apr 12; 383(9925):1313-1324. PubMed ID: 24485548
    [Abstract] [Full Text] [Related]

  • 29. Combined measles-mumps-rubella-varicella vaccine and febrile convulsions: the risk considered in the broad context.
    Casabona G, Berton O, Singh T, Knuf M, Bonanni P.
    Expert Rev Vaccines; 2023 Apr 12; 22(1):764-776. PubMed ID: 37642012
    [Abstract] [Full Text] [Related]

  • 30. Comparison of the safety and immunogenicity of a refrigerator-stable versus a frozen formulation of ProQuad (measles, mumps, rubella, and varicella virus vaccine live).
    Bernstein HH, Eves K, Campbell K, Black SB, Twiggs JD, Reisinger KS, Conti RM, Flodmark CE, Rombo L, Klopfer S, Schödel F, Hartzel J, Kuter BJ, Refrigerator-Stable Formulation Study Group for ProQuad.
    Pediatrics; 2007 Jun 12; 119(6):e1299-305. PubMed ID: 17502347
    [Abstract] [Full Text] [Related]

  • 31. Measles-mumps-rubella-varicella combination vaccine (ProQuad): a guide to its use in children in the E.U.
    Scott LJ.
    Paediatr Drugs; 2015 Apr 12; 17(2):167-74. PubMed ID: 25732634
    [Abstract] [Full Text] [Related]

  • 32. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T, Bernstein DI, Block SL, Hilty M, Keyserling HL, Marchant C, Marshall H, Richmond P, Yogev R, Cordova J, Cho I, Mendelman PM, LAIV Study Group.
    Pediatrics; 2008 Mar 12; 121(3):508-16. PubMed ID: 18310199
    [Abstract] [Full Text] [Related]

  • 33. Safety and immunogenicity of a booster dose of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine coadministered with measles-mumps-rubella-varicella vaccine in children aged 12 to 16 months.
    Vesikari T, Karvonen A, Lindblad N, Korhonen T, Lommel P, Willems P, Dieussaert I, Schuerman L.
    Pediatr Infect Dis J; 2010 Jun 12; 29(6):e47-56. PubMed ID: 20508478
    [Abstract] [Full Text] [Related]

  • 34. Vaccines for measles, mumps, rubella, and varicella in children.
    Di Pietrantonj C, Rivetti A, Marchione P, Debalini MG, Demicheli V.
    Cochrane Database Syst Rev; 2020 Apr 20; 4(4):CD004407. PubMed ID: 32309885
    [Abstract] [Full Text] [Related]

  • 35. Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children.
    Shinefield HR, Black SB, Staehle BO, Matthews H, Adelman T, Ensor K, Li S, Chan I, Heyse J, Waters M, Chan CY, Vessey SJ, Kaplan KM, Kuter BJ, Kaiser Permanente Medical Team for Varivax.
    Pediatr Infect Dis J; 2002 Jun 20; 21(6):555-61. PubMed ID: 12182381
    [Abstract] [Full Text] [Related]

  • 36. Immunogenicity and safety of the combined vaccine for measles, mumps, and rubella isolated or combined with the varicella component administered at 3-month intervals: randomised study.
    Santos EMD, Noronha TG, Alves IS, Cruz RLS, Ferroco CLV, Brum RC, Oliveira PMN, Siqueira MM, Lima MC, Ramos FLP, Bragagnolo CM, Camacho LAB, Maia MLS.
    Mem Inst Oswaldo Cruz; 2019 Mar 07; 114():e180517. PubMed ID: 30843921
    [Abstract] [Full Text] [Related]

  • 37. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.
    Parment PA, Svahn A, Rudén U, Bråkenhielm G, Storsaeter J, Akesson L, Linde A.
    Scand J Infect Dis; 2003 Mar 07; 35(10):736-42. PubMed ID: 14606613
    [Abstract] [Full Text] [Related]

  • 38. Combination measles, mumps, rubella and varicella vaccine.
    Arbeter AM, Baker L, Starr SE, Levine BL, Books E, Plotkin SA.
    Pediatrics; 1986 Oct 07; 78(4 Pt 2):742-7. PubMed ID: 3763291
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.